Business ❯Healthcare ❯Pharmaceuticals ❯Drug Development

Weight Loss Drugs

Lilly’s Oral GLP-1 Pill Underperforms Wegovy in Late-Stage Trial

Lilly’s pill underperformance prompted investor sell-off, triggering price cuts plus lawsuits by Novo Nordisk to protect its GLP-1 market lead.

Viking Therapeutics Advances Weight-Loss Drug, Shaking Up Market Leaders